Shriti Patel, MD Associate Program Director of Psychiatry Residency Eastern Virginia Medical School Department of Psychiatry and Behavioral Sciences

Similar documents
Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

The place for treatments of associated neuropsychiatric and other symptoms

BEHAVIORAL PROBLEMS IN DEMENTIA

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Psychosis and Agitation in Dementia

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

Management of Behavioral Problems in Dementia

Psychotropic Medication Use in Dementia

USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE?

NeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M.

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

Depression in Late Life

11/11/2016. Disclosures. Natural history of BPSD. Objectives. Assessment of BPSD. Behavioral Management of Persons with Alzheimer s Disease

MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

MANAGEMENT OF NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

Pharmacological Treatment of Aggression in the Elderly

Recognition and Management of Behavioral Disturbances in Dementia

Management of the Acutely Agitated Long Term Care Patient

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

The Agitated. Older Patient: old. What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003

A Basic Approach to Mood and Anxiety Disorders in the Elderly

Antipsychotic Medications

Depression in Older Adults. Paul Boulware, MD Arizona Neurological Institute April 22, 2012

Life is a miserable thing. I have decided to spend my life thinking about it. Irvin D. Yalom, The Schopenhauer Cure

Supplementary Online Content

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?

Psychotropic Strategies Handout Package

DEMENTIA AND MEDICATION

Psychotropic Medication. Including Role of Gradual Dose Reductions

Treatment of behavioral and psychological symptoms of dementia: a systematic review

Delirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches

Assessment and management of behavioral and psychological symptoms of dementia

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

Handout for the Neuroscience Education Institute (NEI) online activity: First-Episode Schizophrenia: Setting the Stage for Successful Outcomes

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease

Depression and Suicide in Older Adults. William T. Regenold, M.D.C.M. Associate Professor of Psychiatry Director, Geriatric Psychiatry Division

Pharmacotherapy of Dementia Behaviors

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care

Drugs, Society and Behavior

Lewy Body Disease. Dementia Education for the First Responder July 27, 2017

Diagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical

Up to 90% of people with dementia experience

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center

Contemporary Psychiatric-Mental Health Nursing. Psychopharmacology. Psychopharmacology - continued. Chapter 7 The Science of Psychopharmacology

Antipsychotics for Dementia Under Control or Over-Prescribed?

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

Cognitive disorders. Dr S. Mashaphu Department of Psychiatry

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Delirium. Assessment and Management

9/24/2012. Amer M Burhan, MBChB, FRCP(C)

Pharmacists in Medication Adherence in Psychiatric Patients

Behavioral and Psychological Symptoms of dementia (BPSD)

Diagnosis and Treatment of Alzhiemer s Disease

Parkinson s Disease Psychosis Treatment in Long-Term Care: Clinical and Operational Considerations

Caring for a Patient or Family Member with Alzheimer s Disease or Related Dementia

Depression: Assessment and Treatment For Older Adults

Introduction to Drug Treatment

9/11/2012. Clare I. Hays, MD, CMD

Major Depressive Disorder (MDD) in Children under Age 6

Acute vs. Maintenance

Acute vs. Maintenance

BIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs

Neuropsychiatric Syndromes

Delirium, Depression and Dementia

PRESCRIBING GUIDELINES

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Acute vs. Maintenance

Risks of Antipsychotics use In Dementia

The Maudsley Prescribing Guidelines in

Things You Might Not Know About Psychotropic Medications But Wish You Did

Dementia With A Twist

Case Report Paradoxical Reaction to Alprazolam in an Elderly Woman with a History of Anxiety, Mood Disorders, and Hypothyroidism

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

4.Do a Mini Mental State Examination on your study buddy.

SUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816

Pediatric Psychopharmacology

Kelly Godecke, MD Department of Psychiatry University of Utah

From Neurodevelopment to Neurodegeneration: Behavioral Issues

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

Depression in the Eldery Handout Package

Charles Bernick, MD, MPH Cleveland Clinic Lou Ruvo Center for Brain Health June 2, 2018

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE

Causes of Transient Incontinence. Geriatrics: Urinary Incontinence, Dementia, and Delirium. Classification of Established Incontinence

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Cambridge University Press Effective Treatments in Psychiatry Peter Tyrer and Kenneth R. Silk Excerpt More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

DELIRIUM. Approach and Management

Transcription:

Shriti Patel, MD Associate Program Director of Psychiatry Residency Eastern Virginia Medical School Department of Psychiatry and Behavioral Sciences

Disclosures Board Certified in Adult and Geriatric Psychiatry I have no potential or actual conflict of interest in relation to this presentation

Question 1 An 86 year old widowed white retired physician is brought to the ED after stating I want to end it all, we are all going to die, what is the point?. He reports insomnia, irritability, feeling lonely. He admits to having a loaded gun at home. Which individual risk factor puts him at highest risk for suicide? a. Former Profession b. Age c. Widowhood d. Access to guns e. Presence of irritability

Answer Question 1 a. Former Profession b. Age c. Widowhood d. Access to guns e. Presence of irritability Recommended Reference 1. Y Conwell et. al. Risk Factors for Suicide in Later Life. Biological Psychiatry. 2002; 52: 193-204 2. Gold, Katherine J., Ananda Sen, and Thomas L. Schwenk. Details on Suicide among U.S. Physicians: Data from the National Violent Death Reporting System. General hospital psychiatry 35.1 (2013): 45 49. PMC. Web. 25 Feb. 2017. 3. Kellerman AL, Rivara FP, Somes G, et al. Suicide in the home in relation to gun ownership. New Eng J Med 1992;327:467 472.

Answer Question 1 Risk factor a characteristic, variable, or hazard that increases the likelihood of development of an adverse outcome, which is measurable, and precedes the outcome.

American Foundation for Suicide Prevention: https://afsp.org/about-suicide/suicide-statistics/ One fourth of all suicides occur in persons 65 Other major risk factors: depression, physical illness, living alone, male sex, substance use Violent suicides (e.g. firearms, hanging) are more common than non-violent methods, despite the potential for drug overdosing Highest risk group: elderly white male over age 85

Answer Question 1 a. physician - higher rate of suicide compared to general population undiagnosed/untreated mental illness treatment less sought out, stigma of receiving treatment better understanding of lethal means (in US firearms, in Europe overdose) c. widowhood being single, suffering loss, is a risk factor, often increasing in later life, but not as significant as age alone. d. access to firearm ready availability is associated with increased risk for suicide Risk changes with quality loaded/unloaded, locked/unlocked, storage Most firearm related suicides have had guns in home for months to years

Question 2 Which of these non-pharmacologic (psychosocial) approaches have the most extensive and consistent evidence supporting its use in managing neuropsychiatric symptoms of a patient with dementia? a. Participation in pleasant events b. Training of caregivers and staff c. Exercise d. Personalized Music

Answer Question 2 a. Participation in pleasant events individual 20 min interactions 2-3 x per week outcomes: less depressive symptoms, some decline in agitation b. Training of caregivers and staff psycho-education, patient centered care, communication strategies outcome: less agitation c. Exercise studied in long term care setting outcomes: decreased NPS, improved physical function d. Personalized Music better than group music outcomes: decreased agitation when administered before times of risk Recommended Reference Chenoweth et. al. Caring for Aged Dementia Care Resident Study (CADRES) of person-centered care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial. Lancet Neurology. 2009; 8(4):317-25. Testad et. al. The effect of staff training on agitation and the use of restraint in nursing home residents with dementia: a singleblind, randomized controlled trial. Journal of Clinical Psychiatry. 2010;71 (1): 80-86.

Question 3 Which of the following medications are FDA approved for dementia with agitated behaviors? a. Valproic Acid b. Citalopram c. Risperidone d. Lorazepam e. None of the Above

Answer Question 3 a. Valproic Acid b. Citalopram c. Risperidone d. Lorazepam e. None of the Above Any medication used for agitation in dementia is off-label. Recommended Reference 1. Reus et al. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients with Dementia. American Journal of Psychiatry. (May 2016) 173:5 2. Fleisher AS, Truran D, Mai JT, et al. Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology. 2011;77(13):1263-1271. doi:10.1212/wnl.0b013e318230a16c. 3. Porsteinsson AP, Drye LT, Pollock BG, et al. Effect of Citalopram on Agitation in Alzheimer s Disease The CitAD Randomized Controlled Trial. JAMA : the journal of the American Medical Association. 2014;311(7):682-691. doi:10.1001/jama.2014.93.

Answer Question 3 evidence is limited, but there is more literature supporting modest efficacy of antipsychotics and citalopram compared to other medications a. valproic acid antiepileptic medication, mood stabilizer Limited small studies suggesting improvement of aggressive behaviors Risk: gait imbalance, tremor, elevated LFT/ammonia, sedation, increased progressive brain volume loss b. citalopram selective serotonin reuptake inhibitor CIT-AD study showed some benefit over 9 week period (at 30mg dose) Risks: cardiac risk factors at doses over 20mg. c. risperidone antipsychotic APA recommends that nonemergency antipsychotic medication should only be used for the treatment of agitation or psychosis in patients with dementia when symptoms are severe, are dangerous, and/or cause significant distress to the patient importance of risk/benefit discussion with caregiver, including FDA black box warning for antipsychotic medications d. lorazepam - benzodiazepine limited small studies showing temporary benefit (1-2 hours) Side effects: oversedation, exacerbation of confusion and disinhibited behaviors, fall risk, tolerance

Question 4 A 67yo man has lost 40 lb in the past 6 months, is weak, spends most of his time in bed, and no longer participates in family activities or watches sporting events on television. His family is concerned that he has a serious undiagnosed medical problem. He tends to sit quietly and let his family answer questions, but when pressed, he indicates that he cannot swallow solids or liquids because his throat is blocked. His family reports that he eats and drinks small amounts. The patient believes he has cancer that the doctors have yet to find. According to the medical records he provides, radiography and computed tomography of the chest are normal, and upper endoscopy is unremarkable. Several sets of blood work have been obtained, none of which indicate dehydration, anemia, or hepatic or renal dysfunction. What is the most effective treatment for his illness? a. Sertraline b. Electroconvulsive Therapy c. Olanzapine d. Donepezil

Answer Question 4 a. Sertraline b. Electroconvulsive Therapy c. Olanzapine d. Donepezil Recommended Reference Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J. ECT. 2001;17(4):244 253. Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London). 2014 Feb; 4(1): 33 54.

Answer Question 4 Delusions have a higher prevalence in late-onset major depression (>60 yo) Psychotic depression has a poorer prognosis than nonpsychotic depression and is less responsive to antidepressants Electroconvulsive Therapy shows better efficacy, faster response, and higher remission rates for management of psychotic depression a. sertraline can treat depression alone, but must also treat somatic symptoms of psychosis rapidly c. olanzapine can treat psychotic symptoms, but must treat underlying depression d. donepezil may be modestly protective for cognition, but not mood

Question 5 76 yo female with memory complaints in context of depression, pain from osteoarthritis, neuropathic pain, along with urinary incontinence, diabetes, dyslipidemia, reflux, hypothyroidism, insomnia. MoCA is 20/30, and attention poor, but no major functional deficits. Her blood work was normal. Amongst the medications in her list, which of these has the lowest risk for confusion? a. oxybutynin b. quetiapine c. mirtazepine d. amitriptyline e. acetaminophen/diphenhydramine

Answer Question 5 a. oxybutynin - anticholinergic b. quetiapine - dose dependent anticholinergic properties c. mirtazapine - at low doses, very weak antagonism of muscarinic receptors d. amitriptyline - anticholinergic e. acetaminophen/diphenhydramine - anticholinergic Recommended Reference: Chew ML, Mulsant BH, Pollock BG, et al. A model of anticholinergic activity of atypical antipsychotic medications. Schizophr Res 2006; 88(1-3): 63 72 https://www.guideline.gov/summaries/summary/49933/american-geriatrics-society-2015-updated-beers-criteria-for-potentiallyinappropriate-medication-use-in-older-adults

Questions? Old age is not a disease - it is strength and survivorship, triumph over all kinds of vicissitudes and disappointments, trials and illnesses. - Maggie Kuhn